D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea · Delayed Price · Currency is KRW 74,200
-3,300 (-4.26%)
Apr 30, 2026, 3:30 PM KST
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 3.25 trillion as of April 30, 2026. Its market cap has increased by 562.79% in one year.
Market Cap
3.25T
Enterprise Value
3.22T
Revenue
4.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
74,200.00
Market Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 3.25T, an increase of 756.32%. That is a compound annual growth rate of 193.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 3.39T | -15.06% |
| Dec 30, 2025 | 4.00T | 678.13% |
| Dec 30, 2024 | 513.61B | 35.32% |
| May 2, 2024 | 379.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Co., Ltd. | 8.37T |
| SK Biopharmaceuticals | 7.97T |
| LigaChem Biosciences | 7.09T |
| Peptron | 6.30T |
| Voronoi | 5.33T |
| OliX Pharmaceuticals | 3.75T |
| SK bioscience | 3.42T |
| PharmaResearch | 3.35T |